SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neochem Bio Solutions Ltd (NEOCHEM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: NEOCHEM Chemicals | Small Cap | Neochem Bio Solution Share Price

BSE Share Price
Not Listed

Neochem Bio Solutions Ltd (NEOCHEM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: NEOCHEM Chemicals | Small Cap | Neochem Bio Solution Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹159 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹7
TTM Sales
₹111 Cr.
Book Value per Share
₹46.1
P/E Ratio
13.24
Lower than its 5-year historical median
Industry PE
50.2
Price to Book (P/B)
2.02
Price to Sales (P/S)
1.44
Lower than its 5-year historical median
EV/EBITDA
8.52
Lower than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
18.62%
Outperforms industry median
Return on Capital Employed (ROCE)
14.38%
Outperforms industry median
Return on Assets (ROA)
3.38%
Operating Profit Margin
10%
Net Profit Margin
3.15%
Gross Profit Margin
6.6%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
26.89%
Operating Profit Growth (1 Year)
-
42.66%
Net Profit Growth (1 Year)
-
69.3%
Asset Quality
Promoter Holding
66.72%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹62 Cr.
Equity
₹17.1 Cr.
Face Value
₹10
All Time Low / High
- / -

Neochem Bio Solutions stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Overvalued

Price Trend

Strong
Q.1 Is Neochem Bio Solutions Ltd a good quality company?
Neochem Bio Solutions Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Neochem Bio Solutions Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Neochem Bio Solutions Ltd vs industry peers?
Neochem Bio Solutions Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 4.7%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Neochem Bio Solutions Ltd?
Promoters hold 66.72% of the Neochem Bio Solutions Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Neochem Bio Solutions Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Neochem Bio Solutions Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'22Mar'23Mar'24TTM
ROCE % 9.4%11.9%14.4%-
Value Creation
Index
-0.3-0.20.0-

Growth Parameters

Sales 48.648.261.2111
Sales YoY Gr.--0.8%26.9%-
Adj EPS 1.91.21.67
YoY Gr.--38%40.5%-
BVPS (₹) 7.88.810.546.1
Adj Net
Profit
11.11.912
Cash Flow from Ops. -1.5-1-0.6-
Debt/CF from Ops. -15.9-27-52.8-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANANA26.9%
Adj EPS NANANA40.5%
BVPSNANANA19.4%
Share Price - - - -

Key Financial Parameters

Mar'22Mar'23Mar'24TTM
Return on
Equity %
2417.718.424.9
Op. Profit
Mgn %
7.38.910NAN
Net Profit
Mgn %
22.33.110.9
Debt to
Equity
5.73.12.7-
Working Cap
Days
02622390
Cash Conv.
Cycle
076930

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Sales494861
Operating Expenses + 454455
Manufacturing Costs222
Material Costs343139
Employee Cost 467
Other Costs 448
Operating Profit 446
Operating Profit Margin (%) 7.2%8.9%10.0%
Other Income + 011
Exceptional Items 000
Interest 123
Depreciation 111
Profit Before Tax 123
Tax 001
Profit After Tax 112
PAT Margin (%) 2.0%2.4%3.2%
Adjusted EPS (₹)1.91.21.7
Dividend Payout Ratio (%)0%0%0%

Valuation of Neochem Bio Solution - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund + 4812
Share Capital 357
Reserves 136
Debt +212432
Long Term Debt151218
Short Term Debt61114
Minority Interest000
Trade Payables171314
Others Liabilities 455
Total Liabilities 465163

Fixed Assets

Net Fixed Assets +121519
Gross Block151819
Accumulated Depreciation340
CWIP 000
Investments 000
Inventories131518
Trade Receivables141417
Cash Equivalents 000
Others Assets 679
Total Assets 465163

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Cash Flow From Operating Activity + -1-1-1
PBT 112
Adjustment 234
Changes in Working Capital -5-5-7
Tax Paid -000
Cash Flow From Investing Activity + -3-3-5
Capex -3-3-5
Net Investments -000
Others 000
Cash Flow From Financing Activity + 446
Net Proceeds from Shares 032
Net Proceeds from Borrowing 5-36
Interest Paid -1-2-3
Dividend Paid 000
Others 161
Net Cash Flow 0-00

Financial Ratio

PARTICULARSMar'22Mar'23Mar'24
Ratios
ROE (%)23.7318.2818.62
ROCE (%)9.3811.8914.38
Asset Turnover Ratio1.050.991.07
PAT to CFO Conversion(x)-1-1-0.5
Working Capital Days
Receivable Days102.40105.3092.20
Inventory Days99.90106.9098.90
Payable Days186179.10130.20

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Neochem Bio Solutions Ltd FAQs

The current trading price of Neochem Bio Solution on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Neochem Bio Solution stood at ₹159.2 Cr

The latest P/E ratio of Neochem Bio Solution as of 31-Dec-1969 is 13.24.

The latest P/B ratio of Neochem Bio Solution as of 31-Dec-1969 is 2.02.

The 52-week high of Neochem Bio Solution is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Neochem Bio Solution is ₹111 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Neochem Bio Solutions Ltd is a below average quality company.

The key valuation ratios of Neochem Bio Solutions Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Neochem Bio Solutions Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Neochem Bio Solutions Ltd

Neochem Bio Solutions was originally formed as a partnership firm under the Indian Partnership Act, 1932 (Partnership Act) in the name and style of ‘M/s Vinayak Dyes & Chemical Industries’, on March 6, 1978. Vinayak Dyes & Chemical Industries was changed to ‘Neochem Technologies’ with effect from January 6, 2006 and further the firm was converted from Partnership Firm to Private Limited company on June 6, 2017 as ‘Neochem Technologies Private Limited’. Furthermore, the name of the company was changed from Neochem Technologies Private Limited to Neochem Bio Solutions Private Limited on March 18, 2025. Subsequently, the company was converted into a public limited company pursuant to a special resolution passed by its shareholders resolution dated March 26, 2025, and the name of the company was changed to ‘Neochem Bio Solutions Limited’ on April 15, 2025.

It is a specialty performance chemical company engaged in the business of manufacturing specialty performance chemicals with a diverse portfolio of over hundreds of customized formulations across four primary product segments namely Polymers, Surfactants, Silicones, and Esters & bio based sustainable solutions. Its products are essential and used in industries such as textile & garment washing, home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber and dyes and pigments. The company is accredited with recognized process certifications such as ISO 9001:2015, ISO 14001 and ISO 45001. Its product certifications include ZDHC Level 3 and GOTS 7.0.

It offers a comprehensive range of textile and garment washing auxiliaries such as pre-treatment, dyeing, finishing, printing and coating applications across all fabric and garment substrates compatible with various processing machines. It manufactures and supplies a diverse range of specialty performance chemicals such as dispersant polymers, anti-foams, specialty surfactants, silicone emulsions, and rheological modifiers for the home and personal care industries. Its water treatment range includes anti-scalant formulations based on high and low molecular weight polymers, along with dispersants, anti-foams, de-colorants and flocculants. For the paint and coating industry, it offers acrylic dispersants, wax emulsion-based additives, anti-foams, and acrylic emulsions. Further, its institutional and industrial cleaning range includes room care, laundry care, kitchen hygiene, and personal hygiene solutions tailored for commercial and industrial use.

Its formulation and product application development initiatives are supported by a dedicated in-house research & development laboratory, and an application research center equipped with advanced testing capabilities and operated by a team of qualified professional including support staff. Its initiatives are directed towards advancing sustainability through the development of bio-based products tailored to meet specific customer requirements.

Business area of the company

The company is engaged in the business of manufacturing specialty performance chemicals with a diverse portfolio of over hundreds of customized formulations across four primary product segments such as Polymers, Surfactants, Silicones, and Esters & bio based sustainable solutions. Its products are essential and used in industries such as textile & garment washing, home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper, etc.

Product segments of the company

  • Polymers
  • Surfactants
  • Silicones
  • Esters & Bio-based Sustainable Solutions

Awards and recognitions

  • 2021: Achieved GOTS 6.0 certification and ZDHC level 1 certification 
  • 2022: Obtained ZDHC Level 3 certification and securing AATCC corporate membership 
  • 2023: Certificate of Registration for ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 
  • 2023: Awarded with Certificate of Participation in the Dye Chem World event. 
  • 2023: Awarded with Proud Supporter in the recognition plaque from the ChromaTexeChem 
  • 2024: Achieved GOTS 7.0 certification

Histrory and millstones

  • 1978: Entered into a partnership firm in the name of Vinayak Dyes & Chemical Industries for carrying on the business of colour, chemicals and auxiliaries. 
  • 1982: Established its first facility at Isanpur, Narol to manufacture textile auxiliaries and pigment emulsions. 
  • 2006: Changed the name of the of partnership firm to Neochem Technologies and established new facility at 19/1 Moraiya, Ahmedabad to manufacture textile auxiliaries and speciality performance chemicals.
  • 2013: Received GOTS 2.0 certification 
  • 2017: Conversion of partnership into a private limited company namely Neochem Technologies Private Limited. 
  • 2019: Increase in installed capacity up to 22,000 metric tons per annum along with GOTS 5.0 certification 
  • 2019: Launch of institutional and industrial cleaning chemical products 
  • 2019: Added warehousing facility with storage capacity of 1350 metric ton of raw material and finished goods. 
  • 2020: Setting up Research and development facility, application research center and upgraded QA& QC laboratory 
  • 2020: Built well-equipped admin office 
  • 2022: Amalgamation of Protek Korchem Private Limited with the company 
  • 2023: Entered into international business in countries like Vietnam, Singapore, Canda, Australia, Indonesia etc. 
  • 2024: Launch of home and personal care ingredients product 
  • 2024: Achieved revenue from operations of more than Rs 6,000 lakhs in Fiscal 2024 
  • 2025: Changed the name of the company to Neochem Bio Solutions Private Limited 
  • 2025: Conversion of private limited company to public limited company 
  • 2025: Achieved revenue from operations of more than Rs 8,400 lakhs in Fiscal 2025

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×